M. Mourits

G. D. de Bock, M. Mourits, De Bock, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Risk-reducing mastectomy in BRCA1/2 mutation carriers: factors influencing uptake and timing.

J. Oosterwijk, G. D. de Bock, J. Jaspers, 2014, Maturitas.

Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer

B. Wolffenbuttel, J. Oosterwijk, G. D. de Bock, 2017, PloS one.

Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups

Vera M Witjes, M. Ausems, N. Hoogerbrugge, 2022, Familial Cancer.

Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation Carriers.

J. Oosterwijk, K. Malone, G. D. de Bock, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hereditary Breast-Ovarian Cancer Team of the University Medical Centre Groningen (UMCG) - a Report

J. Oosterwijk, M. Mourits, J. de Vries, 2005, Hereditary cancer in clinical practice.

University of Groningen Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA 1 or BRCA 2 mutation carriers

H. Hollema, G. H. Bock, M. Mourits, 2017 .

Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.

H. Hollema, J. Bart, J. Oosterwijk, 2012, European journal of cancer.

How Should Genetic Counseling for Ovarian Cancer Be Implemented in a Middle-Income Country? An Insight Based on the Brazilian Scenario

R. Chammas, M. Mourits, S. Maistro, 2018, Journal of global oncology.

One risk fits all?

J. Oosterwijk, G. D. de Bock, M. Mourits, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Survey of Male Sexual Functioning in the General Population in the Northern Netherlands

M. Mourits, E. Lammerink, A. Beek, 2021, Medical Research Archives.

Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report

Aung Ko Win, M. von Knebel Doeberitz, B. Bonanni, 2021, European journal of cancer.

Recurrence and survival after laparoscopy versus laparotomy without lymphadenectomy in early-stage endometrial cancer: Long-term outcomes of a randomised trial.

G. Lunter, P. V. van Kesteren, J. Huirne, 2021, Gynecologic oncology.

Surgical volume and conversion rate in laparoscopic hysterectomy: does volume matter? A multicenter retrospective cohort study

G. D. de Bock, M. Mourits, J. Briët, 2017, Surgical Endoscopy.

Less Gastrointestinal Toxicity After Adjuvant Radiotherapy on a Small Pelvic Field Compared to a Standard Pelvic Field in Patients With Endometrial Carcinoma

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2012, International Journal of Gynecologic Cancer.

Total laparoscopic hysterectomy versus abdominal hysterectomy in the treatment of patients with early stage endometrial cancer

G. H. Bock, M. Mourits, Johanna A Bergsma-Kadijk, 2009 .

Total laparoscopic hysterectomy versus abdominal hysterectomy in the treatment of patients with early stage endometrial cancer: A randomized multi center study

G. D. de Bock, M. Mourits, Johanna A Bergsma-Kadijk, 2009, BMC Cancer.

Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens

H. Hollema, J. Bart, J. Oosterwijk, 2012 .

Peritoneal carcinomatosis after risk‐reducing surgery in BRCA1/2 mutation carriers

T. Rebbeck, M. Greene, L. Massuger, 2018, Cancer.

Feasibility of endometrial sampling by vaginal tampons in women with Lynch syndrome

H. Hollema, G. D. de Bock, M. Mourits, 2020, BMC Women's Health.

Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.

H. Boezen, H. Hollema, A. V. D. Van Der Zee, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Letter commenting on "Patholologic finding in prophylactic oophorectomy specimens in high-risk women" (87:52-6) by Pamela Paley, et al. (, fax: +31-206-685-9607).

H. Hollema, A. V. D. Van Der Zee, M. Mourits, 2004, Gynecologic Oncology.

CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma.

H. Hollema, H. Arts, H. Klip, 2016, European journal of cancer.

Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery.

H. Hollema, A. V. D. Van Der Zee, P. Willemse, 2006, International journal of radiation oncology, biology, physics.

Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in and families: high cancer incidence at older age

J. Oosterwijk, M. Schaapveld, G. H. Bock, 2020 .

Letter Commenting on “Risk-Reducing Salpingo-Oophorectomy (RRSO) in BRCA Mutation Carriers: 846–851 by C. Bethan Powell et al

H. Hollema, M. Mourits, W. Reitsma, 2012, International Journal of Gynecologic Cancer.

Letter commenting on "risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol" in Int J Gynecol Cancer 2011;21: 846-851 by C. Bethan Powell et al.

H. Hollema, M. Mourits, W. Reitsma, 2012, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study

A. Hollestelle, M. Hooning, C. V. van Asperen, 2022, PloS one.

Surgical Menopause and Bilateral Oophorectomy: Effect of Estrogen-Progesterone and Testosterone Replacement Therapy on Psychological Well-being and Sexual Functioning; A Systematic Literature Review.

G. D. de Bock, M. Mourits, A. Stuursma, 2022, The journal of sexual medicine.

Pain evaluation during gynaecological surveillance in women with Lynch syndrome

H. Hollema, G. D. de Bock, M. Mourits, 2016, Familial Cancer.

The impact of mutation position on the gene and family history on ovarian cancer risk in BRCA1/2 mutation carriers

J. Oosterwijk, G. H. Bock, M. Mourits, 2015 .

P32: Genomic aberrations in tamoxifen-induced uterine malignancies following breast cancer

H. Hollema, P. Nederlof, F. V. Leeuwen, 2005 .

Vaginal dryness in primary Sjögren’s syndrome: a histopathological case–control study

A. Vissink, H. Hollema, H. Bootsma, 2020, Rheumatology.

The value of routine follow‐up in patients treated for carcinoma of the vulva

H. Hollema, M. Mourits, A. van der Zee, 2003, Cancer.

Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.

N. Aaronson, A. Maas, M. Hooning, 2022, American journal of obstetrics and gynecology.

Re: Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: a prospective randomized study.

G. D. de Bock, M. Mourits, Claudia B M Bijen, 2009, Gynecologic oncology.

Radical Surgery in Patients With Residual Disease After (Chemo)Radiation for Cervical Cancer

H. Hollema, A. V. D. Van Der Zee, H. Klip, 2014, International Journal of Gynecologic Cancer.

Characteristics of Lynch syndrome associated ovarian cancer.

H. Hollema, R. Zweemer, G. D. de Bock, 2018, Gynecologic oncology.

Early salpingectomy ( TUbectomy ) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA 1 / 2 mutation carriers ( TUBA study )

A. Maas, E. Adang, R. Zweemer, 2017 .

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

A. Whittemore, L. Kiemeney, S. Cross, 2016, Nature Communications.

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study

A. Maas, E. Adang, H. V. van Doorn, 2015, BMC Cancer.

Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands.

M. Adank, M. Kriege, R. Zweemer, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2019, Nature Genetics.

Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age

J. Oosterwijk, M. Schaapveld, G. H. Bock, 2010, Breast Cancer Research and Treatment.

Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis.

Vera M Witjes, T. Bosse, M. Ausems, 2021, Gynecologic oncology.

Vulvar carcinoma

H. Hollema, M. Mourits, A. van der Zee, 2002, Cancer.

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

R. Eeles, J. Hopper, D. Easton, 2021, American journal of obstetrics and gynecology.

Costs and Effects of Abdominal versus Laparoscopic Hysterectomy: Systematic Review of Controlled Trials

K. Vermeulen, G. D. de Bock, M. Mourits, 2009, PloS one.

Age should not be a limiting factor in laparoscopic surgery: a prospective multicenter cohort study on quality of life after laparoscopic hysterectomy

E. R. van den Heuvel, G. D. de Bock, M. Mourits, 2018, Clinical interventions in aging.

Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial.

A. V. D. Van Der Zee, G. D. de Bock, W. Post, 2010, The Lancet. Oncology.

Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: Pooled results from three countries

W. E. Hoogendoorn, H. Hollema, L. Bernstein, 2012, Breast Cancer Research.

Implementing an advanced laparoscopic procedure by monitoring with a visiting surgeon.

A. V. D. Van Der Zee, G. D. de Bock, M. Mourits, 2010, Journal of minimally invasive gynecology.

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2021, Nature Communications.

Patterns and frequency of recurrences of squamous cell carcinoma of the vulva.

G. D. de Bock, M. Mourits, A. van der Zee, 2006, Gynecologic oncology.

Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas.

T. Severson, E. Nevedomskaya, W. Zwart, 2016, Cancer research.

No (wo)man is an island--the influence of physicians' personal predisposition to labia minora appearance on their clinical decision making: a cross-sectional survey.

B. van der Lei, M. Mourits, W. Reitsma, 2011, The journal of sexual medicine.

Laparoscopic hysterectomy is preferred over laparotomy in early endometrial cancer patients, however not cost effective in the very obese.

A. V. D. Van Der Zee, K. Vermeulen, G. D. de Bock, 2011, European journal of cancer.

Sexual functioning of cervical cancer survivors: a review with a female perspective.

G. D. de Bock, A. Reyners, M. Mourits, 2012, Maturitas.

Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study.

N. Aaronson, H. Valdimarsdottir, L. Massuger, 2017, European journal of cancer.

Pelvic high-grade serous carcinoma in BRCA1 and BRCA2 mutation carriers

H. Hollema, G. H. Bock, M. Mourits, 2013 .

Ovarian cancer in BRCA1/2 mutation carriers: The impact of mutation position and family history on the cancer risk.

J. Oosterwijk, G. H. Bock, M. Mourits, 2015, Maturitas.

Cost effectiveness of laparoscopy versus laparotomy in early stage endometrial cancer: a randomised trial.

Geertruida H de Bock, A. V. D. Van Der Zee, K. Vermeulen, 2011, Gynecologic oncology.

Management of extracolonic tumours in patients with Lynch syndrome.

H. Hollema, J. Kleibeuker, R. Sijmons, 2009, The Lancet. Oncology.

The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer

H. Hollema, G. D. de Bock, M. Mourits, 2010, International journal of cancer.

Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits

E. John, D. Easton, A. Antoniou, 2022, Journal of the National Cancer Institute.

Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study

O. Dekkers, C. V. van Asperen, T. Bosse, 2021, Journal of the National Cancer Institute.

PMS2-associated Lynch syndrome: Past, present and future

M. Kloor, K. Kok, R. Sijmons, 2023, Frontiers in Oncology.

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?

J. Oosterwijk, G. D. de Bock, M. Mourits, 2009, International journal of cancer.

Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors

H. V. van Doorn, R. Zweemer, J. Custers, 2022, Supportive Care in Cancer.

Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.

H. Hollema, A. V. D. Van Der Zee, E. D. de Vries, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors

H. Hollema, J. Bart, C. V. van Asperen, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.

C. V. van Asperen, G. D. de Bock, C. Kets, 2016, European journal of cancer.

E. Adang, H. V. van Doorn, R. Zweemer, 2015, BMC Cancer.

Effect of Tamoxifen on the Endometrium and the Menstrual Cycle of Premenopausal Breast Cancer Patients

H. Boezen, H. Hollema, E. D. de Vries, 2009, International Journal of Gynecologic Cancer.

Estrogen receptor α wields treatment-specific enhancers between morphologically similar endometrial tumors

E. Nevedomskaya, W. Zwart, H. Hollema, 2017, Proceedings of the National Academy of Sciences.

Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: Pooled results from three countries

W. E. Hoogendoorn, H. Hollema, L. Bernstein, 2012, Breast Cancer Research.

Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer

W. E. Hoogendoorn, H. Hollema, P. Nederlof, 2007, Breast Cancer Research and Treatment.

Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy

A. Absalom, S. Bakker, J. Oosterwijk, 2018, Familial Cancer.

MLH1 and MSH2 protein expression as a pre‐screening marker in hereditary and non‐hereditary endometrial hyperplasia and cancer

H. Hollema, R. Hofstra, E. de Vries, 2001, International journal of cancer.

Experiences of patients and health care professionals on the quality of telephone follow-up care during the COVID-19 pandemic: a large qualitative study in a multidisciplinary academic setting

Gera A. Welker, A. Reyners, B. V. van Munster, 2022, BMJ Open.

Determinants of health-related quality of life in elderly ovarian cancer patients: The role of frailty and dependence.

G. D. de Bock, M. Mourits, M. Jalving, 2019, Gynecologic oncology.

Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study)

M. Hauptmann, N. Aaronson, A. Maas, 2020, JMIR research protocols.

M. Hauptmann, N. Aaronson, A. Maas, 2020 .

Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers

M. Greuter, J. Oosterwijk, G. D. de Bock, 2012, Cancer Prevention Research.

Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA 1 and BRCA 2 Mutation Carriers

M. Greuter, W. Demark-Wahnefried, D. Leroith, 2012 .

Managing hereditary ovarian cancer.

G. D. de Bock, M. Mourits, De Bock, 2009, Maturitas.

Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study

H. Boezen, P. Nieboer, E. Vries, 2009, Breast Cancer Research and Treatment.

Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy

T. Kok, J. Oosterwijk, G. H. Bock, 2011, Breast Cancer Research and Treatment.

BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients

J. Bart, G. D. de Bock, A. H. van der Hout, 2023, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer.

B. V. van Munster, F. Amant, A. Viddeleer, 2021, Gynecologic oncology.

Ovarian cancer

J. Bart, M. Mourits, H. Nijman, 2019, Textbook of Obstetrics and Gynaecology.

Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial.

A. Maas, H. V. van Doorn, R. Zweemer, 2021, JAMA oncology.

Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis

E. Swisher, K. Lu, J. Inthout, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer.

B. Wolffenbuttel, J. Oosterwijk, G. D. de Bock, 2015, European journal of cancer.

Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.

M. Schutte, R. Tollenaar, P. Devilee, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Model of care for women at increased risk of breast and ovarian cancer.

H. Hollema, T. Kok, J. Oosterwijk, 2012, Maturitas.

The Effect of Risk-Reducing Salpingo-Oophorectomy on Breast Cancer Incidence and Histopathological Features in Women with a BRCA1 or BRCA2 Germline Pathogenic Variant

G. D. de Bock, B. van der Vegt, M. Mourits, 2023, Cancers.

Bias Explains Most of the Parent-of-Origin Effect on Breast Cancer Risk in BRCA1/2 Mutation Carriers

M. Adank, A. Jager, C. V. van Asperen, 2016, Cancer Epidemiology, Biomarkers & Prevention.

PREsurgery thoughts – thoughts on prehabilitation in oncologic gynecologic surgery, a qualitative template analysis in older adults and their healthcare professionals

B. V. van Munster, K. Paarlberg, M. Mourits, 2021, Disability and rehabilitation.

Risk assessment for postoperative outcomes in a mixed hospitalized gynecological population by the Dutch safety management system (Veiligheidsmanagementsysteem, VMS) screening tool ‘frail elderly’

B. V. van Munster, K. Paarlberg, M. Mourits, 2021, Archives of Gynecology and Obstetrics.

Long‐term effects of premenopausal risk‐reducing salpingo‐oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross‐sectional study

A. Maas, M. Hooning, C. V. van Asperen, 2023, BJOG : an international journal of obstetrics and gynaecology.

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

A. Whittemore, B. Karlan, E. John, 2023, British Journal of Cancer.

Survival benefit of epithelial ovarian cancer in hormone replacement therapy users: Could it be explained by socio-economic status?

G. D. de Bock, M. Mourits, 2016, Maturitas.

Early detection of breast and ovarian cancer in families with BRCA mutations.

E. Rutgers, J. Oosterwijk, L. Beex, 2005, European journal of cancer.

A Survey of Female Sexual Functioning in the General Dutch Population.

A. V. van Beek, G. D. de Bock, M. Mourits, 2017, The journal of sexual medicine.

Loss of skeletal muscle density during neoadjuvant chemotherapy in older women with advanced stage ovarian cancer is associated with postoperative complications.

B. V. van Munster, F. Amant, A. Viddeleer, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Health and wellbeing after cancer.

A. Maas, M. Rees, M. Mourits, 2017, Maturitas.

Loss of HLA class I and mismatch repair protein expression in sporadic endometrioid endometrial carcinomas

H. Boezen, H. Hollema, M. Mourits, 2012, International journal of cancer.

The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?

E. Adang, M. Ausems, N. Hoogerbrugge, 2023, Gynecologic oncology.

Total laparoscopic hysterectomy versus abdominal hysterectomy in the treatment of patients with early stage endometrial cancer

G. D. de Bock, G. H. Bock, M. Mourits, 2009 .

Genetic counseling of patients with ovarian carcinoma: acceptance, timing, and psychological wellbeing

E. Smets, J. Oosterwijk, M. Buist, 2019, Journal of Community Genetics.

Vulvar carcinoma. The price of less radical surgery.

H. Hollema, A. Zee, M. Mourits, 2002 .